Genmab
Adam Darity currently serves as Vice President of Strategy & Corporate Development at Genmab, leading the Corporate Development team focused on mergers and acquisitions. Prior to Genmab, Adam held several roles at Merck, including Associate Director of Business Development, where responsibilities included leading cross-functional deal teams, negotiating transactions, and identifying new business opportunities. Adam also contributed to strategy development at Merck, advising on M&A transactions and creating market models to support R&D investments. Earlier career experiences include positions at Citi, Double Helix Consulting, and Children's Hospital Boston. Adam holds an AB in Biology from Brown University and an MPH in Health Policy and Management from Columbia University.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.